Indiana Center Helped Bring New Hemophilia Treatment To Light

10/30/2018

By: 

There’s a new treatment now for thousands of patients in the U.S. who live with a rare disorder where blood doesn’t clot. The Food and Drug Administration recently approved Hemlibra, which is produced by Genentech, Inc.

Dr. Amy Shapiro is CEO of the Indiana Hemophilia and Thrombosis Center in Indianapolis.

After eight years of development, the center took part in a clinical trial that lead to the FDA approving the new treatment for patients with Hemophilia A. 

Read more

Source:

Side Effects Public Media Logo

Back to all news

Contact IHTC

8326 Naab Road
Indianapolis, IN 46260

317.871.0000
877.CLOTTER (877.256.8837)
317.871.0010 (fax)